U.S. District Judge Dan Polster has ordered the Drug Enforcement Administration to provide data on opioid prescription sales throughout the nation. This order comes as part of the ongoing multidistrict litigation against pharmaceutical companies that allegedly played a major role in the country's opioid addiction crisis.
As of April 27, all five bellwether trials over the anticoagulant medication Xarelto (rivaroxaban) have ended in outcomes for the defense.
Japan-based Otsuka Pharmaceuticals and its US partner, Bristol-Meyer Squibb, have settled three Abilify lawsuits that were scheduled to go to trial this summer. The plaintiffs, who suffer from gambling addiction and compulsive behavior disorders, allege that their conditions were caused by taking the antipsychotic medication Abilify (aripiprazole).
On May 1st, Ohio's GOP governor John Kasich officially filed a request with the Department of Health and Human Services to institute Trump's new “work requirements” for Medicaid recipients, forcing approximately 700,000 Ohioans to prove they are employed at least half-time or face losing their health care benefits.
Impatient with the slow pace of existing, government-sanctioned space exploration and eager to exploit the commercial potential of outer space, private companies are leading a new rush toward what late Star Trek creator Gene Roddenberry dubbed “the Final Frontier.”
A recently published study from George Washington University looks at how the nation's courts address the issue of public health in lawsuits related to climate change and coal-fired power plants. Because the courts play a pivotal role in the creation and crafting of public policy, the researchers conclude that greater consideration of health impacts could have a positive effect on such policy in the future. Unfortunately, health concerns are not raised in most climate-related cases.
As of March 13th, over 350 lawsuits were pending against drugmakers Sanofi-Aventis and Actavis LLC by women who have suffered permanent hair loss due to the drug Taxotere (docetaxel).
Since Mary Shelly penned the novel Frankenstein; or, The Modern Prometheus some two centuries ago (a story about a scientist named Victor Frankenstein), one of humanity's greatest fears has been that we will wind up creating our own successors – and that those successors will eventually cause our demise. Two recent incidents highlight the dangers of that scenario coming to pass.
Evidence of what is known as Chronic Traumatic Encephalopathy (CTE) among professional football players has been known to medical science for at least twenty years.
Last Thursday, an eight-member jury in a New Jersey state court awarded $23 million in compensatory damages to Mary McGinnis after finding that a pelvic mesh manufactured by C.R. Bard, Inc. was the cause of her pain and suffering. Her husband, Thomas McGinnis, was awarded an additional $10 million for loss of consortium.
In a stunning verdict handed down in a federal court in New Jersey, a jury has ordered pharmaceutical giant Johnson & Johnson and its talc supplier, Imerys, to pay $37 million to a 46-year-old man who alleged that his mesothelioma was caused by his regular use of the defendant's talc-containing products over the course of his lifetime. The trial, which ended yesterday, is the most recent bellwether case over allegations that Johnson & Johnson's flagship products, Baby Powder and Shower to Shower, are carcinogenic.
The last few weeks have not been good ones for billionaire entrepreneur Mark Zuckerberg. In the wake of revelations over its handling of user data, its business practices and how its platform was used to manipulate the 2016 elections, Facebook's stock value has plummeted as investors exit their positions in the company – and so far, there have been four lawsuits filed over its gathering and use of personal information.
On the day following the massive March For Our Lives demonstration, a U.S. firearms manufacturer that has been in business for over two centuries filed for Chapter 11 bankruptcy protection.
On Wednesday, U.S. District Judge George B. Daniels rejected a motion by lawyers for Saudi Arabia to dismiss a lawsuit brought by businesses, insurance companies and families of victims who died or have suffered as the result of the terrorist attacks of September 11, 2001.
U.S. District Judge Peter Messitte issued an order on Wednesday that has cleared the way for a lawsuit against Donald Trump to proceed. As a result, the Attorneys General of Washington D.C. and the state of Maryland now have legal standing to bring their cases against Trump over his alleged violations of the Emoluments Clause of the U.S. Constitution.
The medical community has been dealing with addiction to opioid-based pain medication for over 150 years. It is not a new issue. It has only been in recent years that the rate of addiction has reached crisis proportions. In 2016 alone, opioid overdose claimed 42,000 lives – more than the number of those lost to breast cancer.
Last year, massive cyber-security failures at Equifax exposed personal information on over 145 million consumers to criminal hackers. This information includes Social Security numbers, credit card information, driver's licenses, telephone numbers and more. It is a clear case of gross negligence on part of Equifax, which waited several months before informing consumers.
Despite evidence demonstrating that opioid-based prescriptions are no more effective in controlling pain than their non-opioid counterparts, doctors are protesting a new federal Medicare rule currently under consideration that would allow pharmacists to limit patient access to such medications.
Earlier this week, the current U.S. Attorney General Jefferson Sessions announced that the Department of Justice intends to file a “statement of interest” in filing its own lawsuit against opioid manufacturers. In a media statement, Sessions alleged that opioid manufacturers and distributors had used “false, deceptive, and unfair marketing” in order to market their products.
800.277.1193
Phone